JP2023521330A5 - - Google Patents

Info

Publication number
JP2023521330A5
JP2023521330A5 JP2022561019A JP2022561019A JP2023521330A5 JP 2023521330 A5 JP2023521330 A5 JP 2023521330A5 JP 2022561019 A JP2022561019 A JP 2022561019A JP 2022561019 A JP2022561019 A JP 2022561019A JP 2023521330 A5 JP2023521330 A5 JP 2023521330A5
Authority
JP
Japan
Application number
JP2022561019A
Other languages
Japanese (ja)
Other versions
JP7755597B2 (ja
JP2023521330A (ja
JPWO2021205176A5 (https=
Filing date
Publication date
Priority claimed from GBGB2005331.0A external-priority patent/GB202005331D0/en
Priority claimed from GBGB2017358.9A external-priority patent/GB202017358D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/050866 external-priority patent/WO2021205176A2/en
Publication of JP2023521330A publication Critical patent/JP2023521330A/ja
Publication of JP2023521330A5 publication Critical patent/JP2023521330A5/ja
Publication of JPWO2021205176A5 publication Critical patent/JPWO2021205176A5/ja
Priority to JP2025138496A priority Critical patent/JP2025170345A/ja
Application granted granted Critical
Publication of JP7755597B2 publication Critical patent/JP7755597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022561019A 2020-04-09 2021-04-08 細胞 Active JP7755597B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138496A JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2005331.0 2020-04-09
GBGB2005331.0A GB202005331D0 (en) 2020-04-09 2020-04-09 Cell
GBGB2017358.9A GB202017358D0 (en) 2020-11-02 2020-11-02 Cell
GB2017358.9 2020-11-02
PCT/GB2021/050866 WO2021205176A2 (en) 2020-04-09 2021-04-08 Cell

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138496A Division JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Publications (4)

Publication Number Publication Date
JP2023521330A JP2023521330A (ja) 2023-05-24
JP2023521330A5 true JP2023521330A5 (https=) 2024-02-09
JPWO2021205176A5 JPWO2021205176A5 (https=) 2024-02-09
JP7755597B2 JP7755597B2 (ja) 2025-10-16

Family

ID=75539696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022561019A Active JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Country Status (7)

Country Link
US (1) US20230113183A1 (https=)
EP (1) EP4132963A2 (https=)
JP (2) JP7755597B2 (https=)
CN (1) CN115315439A (https=)
AU (1) AU2021253759A1 (https=)
CA (1) CA3174812A1 (https=)
WO (1) WO2021205176A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201720949D0 (en) 2017-12-15 2018-01-31 Autolus Ltd Cell
JP2024541501A (ja) * 2021-11-25 2024-11-08 ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ Cd95ポリペプチド

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052906B1 (en) 1999-04-16 2006-05-30 Celltech R & D Limited Synthetic transmembrane components
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
US9931386B2 (en) * 2008-06-16 2018-04-03 Atsuo Ochi Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
GB201206559D0 (en) 2012-04-13 2012-05-30 Ucl Business Plc Polypeptide
CA2978186A1 (en) * 2015-03-05 2016-09-09 Fred Hutchinson Cancer Research Center Immunomodulatory fusion proteins and uses thereof
CA2999037A1 (en) * 2015-09-23 2017-03-30 Cytoimmune Therapeutics, LLC Flt3 directed car cells for immunotherapy
AU2018236461B2 (en) * 2017-03-17 2025-03-27 Fred Hutchinson Cancer Center Immunomodulatory fusion proteins and uses thereof
GB201716728D0 (en) * 2017-10-12 2017-11-29 Autolus Ltd Cell
GB201720949D0 (en) * 2017-12-15 2018-01-31 Autolus Ltd Cell
EP3810753A1 (en) * 2018-06-19 2021-04-28 Autolus Limited Cell
CA3114788A1 (en) * 2018-09-28 2020-04-02 Memorial Sloan-Kettering Cancer Center Immunoresponsive cells expressing dominant negative fas and uses thereof

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)